GlassScriptPhysician profile
David C Hatch
NPI 1003295643
$19,225.95
in general payments reported to CMS, 2019-2025
42 companies · $4,275 in 2025
The $4,275 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $2,707 · 2021: $2,741 · 2022: $6,384 · 2023: $1,528 · 2024: $1,119 · 2025: $4,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,328 · Food and Beverage: $3,142 · Travel and Lodging: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,328.00 |
| Food and Beverage | $3,141.81 |
| Travel and Lodging | $451.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,785.11 | 2022 | |
| International Rehabilitative Sciences, INC | $3,411.11 | 2025 | Rs-4i Plus With Intersperse |
| Impactortho, INC. | $2,271.13 | 2020-2023 | |
| Paragon 28, INC. | $1,869.12 | 2020-2021 | |
| Smith+Nephew, INC. | $1,432.25 | 2019-2025 | Grafix Pl, Collagenase Santyl, Hallu Lock |
| Stryker Corporation | $1,393.19 | 2023-2025 | Prostep, Ortholoc 3di, N/A |
| Integra Lifesciences Corporation | $1,099.72 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $781.69 | 2020-2022 | |
| Medtronic, INC. | $368.39 | 2021-2022 | |
| Austin Medical Ventures INC | $154.17 | 2025 | Synthecure |
| Medshape, INC. | $149.92 | 2025 | |
| Nevro Corp. | $136.21 | 2023-2024 | Senza |
| Treace Medical Concepts, INC. | $107.50 | 2023-2025 | |
| Silk Road Medical, INC. | $106.25 | 2019 | |
| Paratek Pharmaceuticals, INC. | $105.78 | 2022-2025 | Nuzyra |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $97.51 | 2019-2025 | Physio-Stim |
| Organogenesis INC. | $94.93 | 2020-2023 | Puraply |
| Tactile Systems Technology INC | $86.18 | 2019-2022 | |
| Depuy Synthes Sales INC. | $79.72 | 2025 | Na |
| Biowound Solutions, INC. | $75.36 | 2025 | Bio-Connekt |
| W. L. Gore & Associates, INC. | $68.05 | 2023-2024 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Hartmann USA, INC. | $59.77 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Osiris Therapeutics INC. | $57.64 | 2019 | |
| Solventum Corporation | $41.73 | 2024-2025 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Janssen Pharmaceuticals, INC | $36.23 | 2022 | |
| Krystal Biotech INC | $35.47 | 2023 | Vyjuvek |
| Terumo Medical Corporation | $35.47 | 2022 | |
| Cook Medical LLC | $34.20 | 2022-2023 | Zilver Ptx |
| Abbvie INC. | $28.09 | 2021-2022 | |
| Protega Pharmaceutials INC | $23.33 | 2025 | Roxybond |
| Abbott Laboratories | $22.12 | 2025 | Eterna |
| Fusion Orthopedics USA, LLC | $19.99 | 2025 | |
| Zimmer Biomet Holdings, INC. | $18.65 | 2023 | A.L.P.S. |
| Averitas Pharma INC. | $18.02 | 2023 | Qutenza |
| Ibsa Pharma INC. | $17.87 | 2023 | Tirosint, Licart |
| Amgen INC. | $17.75 | 2025 | Krystexxa |
| Biocompatibles, INC. | $17.63 | 2019 | |
| Horizon Therapeutics Plc | $16.24 | 2023 | Krystexxa |
| Grt US Holding, INC. | $16.20 | 2022 | |
| Djo, LLC | $15.05 | 2022 | |
| Merck Sharp & Dohme LLC | $12.05 | 2019 | |
| Advanced Oxygen Therapy INC. | $9.16 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hatch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.